JP2002504933A - 皮膚の老化及び傷の治療に用いられる細胞移動剤 - Google Patents
皮膚の老化及び傷の治療に用いられる細胞移動剤Info
- Publication number
- JP2002504933A JP2002504933A JP50590299A JP50590299A JP2002504933A JP 2002504933 A JP2002504933 A JP 2002504933A JP 50590299 A JP50590299 A JP 50590299A JP 50590299 A JP50590299 A JP 50590299A JP 2002504933 A JP2002504933 A JP 2002504933A
- Authority
- JP
- Japan
- Prior art keywords
- cell
- indole
- agent
- transfer agent
- cell transfer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
- A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Birds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 治療上有効な量のインドール-3-酢酸及びその誘導体を含んでいる細胞移 動剤。 2. 誘導体はインドール-3-アセチル-L−フェニルアラニンを含んでいる請求 項1の細胞移動剤。 3. 誘導体はインドール-3-アセチルグリシンを含んでいる請求項1の細胞移 動剤。 4. 誘導体はインドール-3-アセチル-L-アスパラギン酸を含んでいる請求項1 の細胞移動剤。 5. 誘導体はインドール-3-アセチル-L-アラニンを含んでいる請求項1の細胞 移動剤。 6. 誘導体はインドール-3-酢酸メチルエステルを含んでいる請求項1の細胞 移動剤。 7. 0.1ppm〜1000ppmのインドール-3-酢酸又はその誘導体を含んでい る請求項1の細胞移動剤。 8. 0.10ppm〜250ppmのインドール-3-酢酸又はその誘導体を含んでい る請求項1の細胞移動剤。 9. 化学剥皮剤をさらに含んでいる請求項1の細胞移動剤。 10.治療上有効な量のインドール-3-酢酸又はその誘導体を組織へ供給するこ とにより組織傷の治癒を促進する傷治癒促進方法。 11.供給は表面塗布により行われる請求項10の方法。 12.供給は注射により行われる請求項10の方法。 13.供給は摂取により行われる請求項10の方法。 14.供給は吸入により行われる請求項10の方法。 15.皮膚の老化を治療することをさらに含んでいる請求項10の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88477997A | 1997-06-30 | 1997-06-30 | |
US08/884,779 | 1997-06-30 | ||
PCT/US1998/013675 WO1999000079A1 (en) | 1997-06-30 | 1998-06-30 | Skin aging and wound treatment using cell migration agents |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002504933A true JP2002504933A (ja) | 2002-02-12 |
Family
ID=25385375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50590299A Pending JP2002504933A (ja) | 1997-06-30 | 1998-06-30 | 皮膚の老化及び傷の治療に用いられる細胞移動剤 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1009345A4 (ja) |
JP (1) | JP2002504933A (ja) |
AU (1) | AU8379798A (ja) |
WO (1) | WO1999000079A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMO20060339A1 (it) * | 2006-10-23 | 2008-04-24 | Clelia Barini | Metodo cosmetico di tonificazione del derma |
FR2929115B1 (fr) * | 2008-03-31 | 2010-06-04 | Exsymol Sa | Utilisation cosmetique de composes conjugues d'auxines indoliques. |
FR2984122B1 (fr) * | 2011-12-16 | 2014-08-01 | Syntivia | Composition cosmetique pour stimuler les fonctions cellulaires anti-vieillissement de la peau |
EP4167943A1 (en) * | 2020-06-19 | 2023-04-26 | Unilever IP Holdings B.V. | Use of indole compounds for treating signs of skin aging |
WO2021254754A1 (en) * | 2020-06-19 | 2021-12-23 | Unilever Ip Holdings B.V. | Use of indole compounds for treating signs of skin aging |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1269573A (fr) * | 1959-06-09 | 1961-08-18 | Produits de beauté à base d'auxines | |
US3271394A (en) * | 1964-12-31 | 1966-09-06 | Merck & Co Inc | Alpha-indolyl-3-acetic acid esters |
US4847283A (en) * | 1983-01-10 | 1989-07-11 | Harendza Harinxma Alfred J | Ointment and method for treating skin lesions due to herpes virus |
FR2597339A1 (fr) * | 1986-04-16 | 1987-10-23 | Bounan Michel | Trois substances a activite antitumorale preparees par dilutions successives d'hormones vegetales de croissance. |
-
1998
- 1998-06-30 JP JP50590299A patent/JP2002504933A/ja active Pending
- 1998-06-30 EP EP98934222A patent/EP1009345A4/en not_active Withdrawn
- 1998-06-30 WO PCT/US1998/013675 patent/WO1999000079A1/en not_active Application Discontinuation
- 1998-06-30 AU AU83797/98A patent/AU8379798A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU8379798A (en) | 1999-01-19 |
EP1009345A1 (en) | 2000-06-21 |
EP1009345A4 (en) | 2002-03-13 |
WO1999000079A1 (en) | 1999-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5770582A (en) | Pharmaceutical compositions containing deoxyribonucleosides for wound healing | |
EP0827743B1 (en) | Use of histone decarboxylase inhibitors for treating fibrosis | |
JP3527890B2 (ja) | フマル酸アルキル水素エステルからなる乾癬、乾癬性関節炎、神経皮膚炎および限局性回腸炎クローン病の治療剤 | |
CZ277718B6 (en) | Transdermal therapeutic system | |
CN106456662A (zh) | 口服给药的戊聚糖多硫酸盐的组合物及其使用方法 | |
TW200401650A (en) | Pharmaceutical composition for the treatment of radiation-induced skin damage | |
KR20010013349A (ko) | 상처 치료를 위한 기구 및 방법 | |
JP4987209B2 (ja) | 瘢痕形成作用を有する医薬品を製造するためのビグアニド誘導体の使用 | |
US11369685B2 (en) | Compositions and methods for wound treatment | |
WO2019103926A1 (en) | P38 inhibitors for the treatment of fshd | |
RU2096044C1 (ru) | Ветеринарный имплантируемый препарат для регулирования биологического ритма животных | |
CZ374497A3 (cs) | Způsob inhibice migrace buněk vaskulárního hladkého svalstva | |
US6174541B1 (en) | Skin aging and wound treatment using cell migration agents | |
JPH10158169A (ja) | 塩化トロスピウムを含んだ医薬製剤、その調整方法および使用方法 | |
Liu et al. | A novel nitric oxide-releasing gel for diabetic wounds | |
JP2002504933A (ja) | 皮膚の老化及び傷の治療に用いられる細胞移動剤 | |
JPS62501705A (ja) | 腫瘍性疾患の治療に用いるプログルミド含有医薬組成物 | |
EP0420862B1 (en) | Pharmaceutical composition containing deoxyribonucleosides for wound healing | |
JP2002526411A (ja) | 網膜病理を治療するためのジルチアゼムの使用 | |
EP1686969A1 (en) | Transdermal pharmaceutical spray formulations comprising a vp/va copolymer and a non-aqueous vehicle | |
JP2003514856A (ja) | 細菌性疾患を経皮治療するためのプロウロムチリン(pleuromutilin)誘導体の使用 | |
Tator et al. | The effect of exogenous thyroid hormones on functional recovery of the rat after acute spinal cord compression injury | |
EP0313945A2 (de) | Mittel zur Behandlung des Bluthochdrucks und der Herzinsuffizienz | |
CN102970986B (zh) | 含有吡罗昔康的骨架型贴剂以及局部治疗急性和慢性疼痛及其相关炎症的方法 | |
CN110464713B (zh) | 奇壬醇抗风湿关节炎的透皮贴剂制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20031216 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20040302 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040630 |
|
A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20040930 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20041014 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20041014 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20041014 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20041202 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20041202 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20041202 |
|
A912 | Removal of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20050407 |